TY - JOUR
T1 - Management of nocturnal hypertension
T2 - An expert consensus document from Chinese Hypertension League
AU - Liu, Jing
AU - Li, Yan
AU - Zhang, Xinjun
AU - Bu, Peili
AU - Du, Xueping
AU - Fang, Lizheng
AU - Feng, Yingqing
AU - Guo, Yifang
AU - Han, Fei
AU - Jiang, Yinong
AU - Li, Yuming
AU - Lin, Jinxiu
AU - Liu, Min
AU - Liu, Wei
AU - Long, Mingzhi
AU - Mu, Jianjun
AU - Sun, Ningling
AU - Wu, Hao
AU - Xie, Jianhong
AU - Xie, Jingyuan
AU - Xie, Liangdi
AU - Yu, Jing
AU - Yuan, Hong
AU - Zha, Yan
AU - Zhang, Yuqing
AU - Zhu, Shanzhu
AU - Wang, Jiguang
N1 - Publisher Copyright:
© 2023 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC.
PY - 2024/1
Y1 - 2024/1
N2 - Nocturnal hypertension is highly prevalent among Chinese and Asian populations, which is mainly attributed to high salt intake and high salt sensitivity. Nocturnal hypertension increases the risk of cardiovascular and all-cause mortality, independent of daytime blood pressure (BP). However, it can usually be detected by 24-h ambulatory BP monitoring, rather than routine office or home BP measurement, thus is often underdiagnosed in clinical practice. Currently, no specific guidance is available for the management of nocturnal hypertension in China or worldwide. Experts from the Chinese Hypertension League summarized the epidemiologic and pathophysiologic characteristics and clinical phenotype of nocturnal hypertension and provided consensus recommendations on optimal management of nocturnal hypertension, with the goal of maximally reducing the cardiovascular disease risks. In this consensus document, 24-h ABPM is recommended for screening and diagnosis of nocturnal hypertension, especially in the elderly, patients with diabetes, chronic kidney diseases, obstructive sleep apnea and other conditions prone to high nocturnal BP. Lifestyle modifications including salt intake restriction, exercise, weight loss, sleep improvement, and mental stress relief are recommended. Long-acting antihypertensive medications are preferred for nocturnal and 24-h BP control. Some newly developed agents, renal denervation, and other device-based therapy on nocturnal BP reduction are evaluated.
AB - Nocturnal hypertension is highly prevalent among Chinese and Asian populations, which is mainly attributed to high salt intake and high salt sensitivity. Nocturnal hypertension increases the risk of cardiovascular and all-cause mortality, independent of daytime blood pressure (BP). However, it can usually be detected by 24-h ambulatory BP monitoring, rather than routine office or home BP measurement, thus is often underdiagnosed in clinical practice. Currently, no specific guidance is available for the management of nocturnal hypertension in China or worldwide. Experts from the Chinese Hypertension League summarized the epidemiologic and pathophysiologic characteristics and clinical phenotype of nocturnal hypertension and provided consensus recommendations on optimal management of nocturnal hypertension, with the goal of maximally reducing the cardiovascular disease risks. In this consensus document, 24-h ABPM is recommended for screening and diagnosis of nocturnal hypertension, especially in the elderly, patients with diabetes, chronic kidney diseases, obstructive sleep apnea and other conditions prone to high nocturnal BP. Lifestyle modifications including salt intake restriction, exercise, weight loss, sleep improvement, and mental stress relief are recommended. Long-acting antihypertensive medications are preferred for nocturnal and 24-h BP control. Some newly developed agents, renal denervation, and other device-based therapy on nocturnal BP reduction are evaluated.
KW - clinical management
KW - expert consensus
KW - nocturnal hypertension
UR - https://www.scopus.com/pages/publications/85180189312
U2 - 10.1111/jch.14757
DO - 10.1111/jch.14757
M3 - 文章
C2 - 38126623
AN - SCOPUS:85180189312
SN - 1524-6175
VL - 26
SP - 71
EP - 83
JO - Journal of Clinical Hypertension
JF - Journal of Clinical Hypertension
IS - 1
ER -